Cleerly Heart Analysis

Description

Cleerly is an AI-driven platform designed to transform the diagnosis and treatment of coronary artery disease (CAD). Utilizing advanced coronary CT angiography (CCTA), Cleerly's tools provide detailed insights into plaque volume, composition, and stenosis severity, offering a comprehensive view of a patient's heart health. The platform's AI capabilities allow for non-invasive detection and characterization of all plaque types, including high-risk soft plaque, and assess ischemia likelihood with high accuracy. Cleerly's solutions are supported by clinical evidence from trials like CREDENCE and PACIFIC, demonstrating diagnostic accuracy comparable to invasive gold standards.

Cleerly's platform integrates with existing workflows, such as PowerScribe, to streamline reporting and reduce manual transcription errors. The software also supports serial CCTA comparisons, enabling physicians to track changes in plaque burden over time and tailor treatment plans accordingly. Cleerly's analysis is non-invasive, requiring only a CCTA scan, which exposes patients to minimal radiation.

The platform is available through a doctor's order and is covered by many major insurance providers, including Aetna, UnitedHealthcare, and Cigna. However, Cleerly's services are currently only available within the United States. The platform empowers healthcare providers to make informed decisions, potentially reducing the need for additional testing and enhancing diagnostic confidence.

Cleerly's mission is to establish a new standard of precision heart care, aiming to eliminate heart attacks by providing actionable insights into coronary artery disease. The platform is designed for use by cardiologists and primary care providers, offering a complete view of plaque and its risks, which standard checkups might miss. By providing clarity and confidence in heart health, Cleerly helps doctors personalize care plans and track heart health over time.

Cleerly Heart Analysis's Core Features

• AI-enabled coronary artery disease diagnostics

• Non-invasive plaque and stenosis analysis

• Integration with PowerScribe for streamlined reporting

• Serial CCTA comparison for tracking plaque changes

• High diagnostic accuracy in clinical trials

• Insurance coverage by major providers

• Web-based solution for coronary CT angiography

• Personalized treatment insights for physicians

How to use Cleerly Heart Analysis?

1. 1

   Consult: Discuss with your doctor about Cleerly analysis

2. 2

   Order: Doctor orders CCTA and Cleerly analysis

3. 3

   Scan: Undergo a CCTA scan at an imaging center

4. 4

   Receive: Doctor receives results within one business day

Cleerly Heart Analysis's Use Cases

• Early CAD Detection
• Plaque Progression Tracking
• Non-Invasive Ischemia Assessment
• Personalized Treatment Planning
• Insurance Coverage

FAQ from Cleerly Heart Analysis

• What is a Cleerly heart scan analysis?

  Cleerly analyzes CCTA images using AI to measure plaque in arteries, providing a clear picture of heart attack risk.

• Is the Cleerly analysis safe?

  Yes, both the CCTA scan and Cleerly analysis are non-invasive, meaning nothing enters your heart or arteries.

• How does Cleerly help reduce heart disease risk?

  Cleerly provides a complete view of plaque, helping doctors catch early signs of heart disease and guide treatment.

• Is Cleerly covered by insurance?

  Cleerly is covered by many major insurance providers, including Aetna, UnitedHealthcare, and Cigna.

• How long until my doctor receives my results?

  Once you complete your scan, your doctor typically has your results within one business day.

• What scan is needed before a Cleerly analysis?

  A coronary CT angiogram (CCTA) is needed before a Cleerly analysis.

• Is Cleerly available outside the United States?

  Cleerly is currently only available within the United States.

• How does Cleerly personalize my care plan?

  Cleerly results help doctors tailor treatment plans based on individual plaque and heart health insights.